DNA Methylation as a Therapeutic and Diagnostic Target in Major Depressive Disorder

被引：8
作者：
Lax, Elad [1 ]
机构：
[1] Ariel Univ, Dept Mol Biol, Ariel, Israel
来源：
FRONTIERS IN BEHAVIORAL NEUROSCIENCE | 2022年 / 16卷
关键词：
epigenetics; DNA methylation; depression; stress; biomarker; SEROTONIN TRANSPORTER GENE; MATERNAL-CARE; ENVIRONMENT INTERACTIONS; PROMOTER METHYLATION; STRESS; BEHAVIOR; SLC6A4; ASSOCIATION; EXPRESSION; ADVERSITY;
D O I：
10.3389/fnbeh.2022.759052
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
[No abstract available]
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Complex trait methylation scores in the prediction of major depressive disorder
    Barbu, Miruna C.
    Amador, Carmen
    Kwong, Alex S. F.
    Shen, Xueyi
    Adams, Mark J.
    Howard, David M.
    Walker, Rosie M.
    Morris, Stewart W.
    Min, Josine L.
    Genetics DNA Methylation Consortium, Chunyu
    Liu, Chunyu
    van Dongen, Jenny
    Ghanbari, Mohsen
    Relton, Caroline
    Porteous, David J.
    Campbell, Archie
    Evans, Kathryn L.
    Whalley, Heather C.
    EBIOMEDICINE, 2022, 79
  • [32] Advances in biosensors for major depressive disorder diagnostic biomarkers
    Dong, Tao
    Yu, Chenghui
    Mao, Qi
    Han, Feng
    Yang, Zhenwei
    Yang, Zhaochu
    Pires, Nuno
    Wei, Xueyong
    Jing, Weixuan
    Lin, Qijing
    Hu, Fei
    Hu, Xiao
    Zhao, Libo
    Jiang, Zhuangde
    BIOSENSORS & BIOELECTRONICS, 2024, 258
  • [33] Pathogenetic and therapeutic applications of microRNAs in major depressive disorder
    Dwivedi, Yogesh
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 64 : 341 - 348
  • [34] Altered DNA methylation of glucose transporter 1 and glucose transporter 4 in patients with major depressive disorder
    Kahl, Kai G.
    Georgi, Karsten
    Bleich, Stefan
    Muschler, Marc
    Hillemacher, Thomas
    Hilfiker-Kleinert, Denise
    Schweiger, Ulrich
    Ding, Xiaoqi
    Kotsiari, Alexandra
    Frieling, Helge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2016, 76 : 66 - 73
  • [35] Stimulated Gene Expression Profiles as a Blood Marker of Major Depressive Disorder
    Spijker, Sabine
    Van Zanten, Jeroen S.
    De Jong, Simone
    Penninx, Brenda W. J. H.
    van Dyck, Richard
    Zitman, Frans G.
    Smit, Jan H.
    Ylstra, Bauke
    Smit, August B.
    Hoogendijk, Witte J. G.
    BIOLOGICAL PSYCHIATRY, 2010, 68 (02) : 179 - 186
  • [36] Clinical and preclinical evaluation of miR-144-5p as a key target for major depressive disorder
    Wu, Xiaodong
    Zhang, Yulong
    Wang, Ping
    Li, Xiaohui
    Song, Zhen
    Wei, Chuke
    Zhang, Qing
    Luo, Bei
    Liu, Zhichun
    Yang, Yingying
    Ren, Zhenhua
    Liu, Huanzhong
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (11) : 3598 - 3611
  • [37] Targeting TNIP1 as a new therapeutic avenue for major depressive disorder
    Hung, Yi-Yung
    Tsai, Ching-Yi
    Lee, Chien-Te
    Fu, Hung-Chun
    Chou, Chen-Kai
    Yang, Yi-Chien
    Chen, Jia-Feng
    Kang, Hong-Yo
    BRAIN BEHAVIOR AND IMMUNITY, 2025, 126 : 214 - 224
  • [38] Therapeutic potential and mechanisms of stem cells in major depressive disorder: a comprehensive review
    Li, Jiaqi
    Wang, Yuqian
    Zhang, Yucheng
    Liu, Mengran
    Rong, Xinao
    Jiang, Jinlan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [39] Leveraging DNA methylation to predict treatment response in major depressive disorder: A critical review
    Dahrendorff, Jan
    Currier, Glenn
    Uddin, Monica
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2024, 195 (07)
  • [40] Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
    Nakaoka, Toshiaki
    Saito, Yoshimasa
    Saito, Hidetsugu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
12345